Sustained metabolic control in latent autoimmune diabetes in adults (LADA) with semaglutide therapy in a patient with multiple autoimmune comorbidities: a case report and literature review
Researchers reported a case of a 55-year-old woman initially diagnosed with type 2 diabetes who was later reclassified as LADA due to positive autoantibodies. After discontinuing metformin and initiating semaglutide, the patient maintained durable glycemic control, significant weight loss, and stable beta-cell function without insulin over five years. A literature review also highlighted limited evidence for GLP-1 receptor agonists in LADA.
What to check after reading
This case underscores the importance of early LADA recognition and personalized treatment, though larger prospective studies are needed to validate the role of GLP-1 receptor agonists in LADA management.
Source
Calendar dates show when a case was added or scheduled. For event dates, check the original source.